Cholangitis is the term used for infection in the common bile duct of the individual. Bile duct is the tube that carries bile juice, which is helpful for digestion, from liver to intestine and gallbladder. The cause of cholangitis is bacterial infection. The bile duct is also known as biliary tract, whose infection leads to morbidity and mortality. The basic symptoms of cholangitis are jaundice, low blood pressure, abdominal pain and fever. If the individual possesses pancreatic cancer, the risk of cholangitis increases to large extent. Its early stage treatment and diagnosis is utterly important. Generally in the trend it has been noticed that people above sixty years of age are largely prone to cholangitis.
Cholangitis cause deficiencies of important fat-soluble vitamins in the body which are not absorbed the body due to less secretion of bile. Its other effect includes liver failure, bile duct cancer or infective cholangitis, if proper precautions are not taken in timely manner. Although many experts believe that it does not have specific effects on the person and hence varies from person to person.
Cholangitis is an uncommon disorder in below forty year age people. A number of tests can be used for its detection such as liver function blood tests, ultrasound test or a liverbiopsy test. Its primary treatment involves medical treatment by ursodeoxycholic acid, complications treatment by injecting antibodies or surgical treatment like liver transplantation. The type of methodology adopted for the treatment depends upon the severances of the disorder.
Changing lifestyle, increasing awareness of healthcare and geriatric population increase are major factors that are expected for increasing growth of market for cholangitis. While other factor which supports the growth of the markets increase in affordability of the healthcaretreatment and diagnoses, in turn has increased the life expectancy of the people. People above sixty years of age, suffer from various disorders; hence increasing geriatric population augments the demand for the therapies for cholangitis market.
The geographical segmentation of cholangitis market is divided into four major segments namely North America, Europe, Asia-Pacific and RoW. North America is expected to remain market leader for global cholangitis disorder due increasing geriatric population along with increasing healthcare awareness. While the markets of Asia-Pacifica and Row are expected to grow at significant pace due to the fact of increasing disposable income and increase in awareness of health care and aging problem.
The market leaders of cholangitis therapies developers include Taiho Pharmaceutical Co. Ltd., Mayo Clinic, Bayer AG, Gilead Sciences, RiemserArzneimittel and Zambon Company SPA.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.